Article info
PDFHepatology
Original article
MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway
- Correspondence to Dr Guisheng Song, Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Minnesota Medical School, MMC 36, VFW Cancer Research Center, V354, 406 Harvard Street SE, Minneapolis, MN 55455, USA; gsong{at}umn.edu
Citation
MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway
Publication history
- Received September 19, 2014
- Revised July 12, 2015
- Accepted July 14, 2015
- First published August 17, 2015.
Online issue publication
December 22, 2016
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
- Data supplement 2 - Online figures
- Data supplement 3 - Online table 1
- Data supplement 4 - Online table 2
- Data supplement 5 - Online table 3
- Data supplement 6 - Online table 4
- Data supplement 7 - Online table 5
- Data supplement 8 - Online table 6
- Data supplement 9 - Online table 7
- Data supplement 10 - Online table 8
- Data supplement 11 - Online table_captions
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/